D.E. Shaw & Co
ARQT icon

D.E. Shaw & Co’s Arcutis Biotherapeutics ARQT Stock Holding History

D.E. Shaw & Co’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.8M Sell
2,496,222
-186,865
-7% -$4.77M 0.05% 585
2025
Q4 		$77.9M Buy
2,683,087
+564,374
+27% +$14.4M 0.06% 507
2025
Q3 		$39.9M Sell
2,118,713
-44,288
-2% -$698K 0.03% 769
2025
Q2 		$30.3M Buy
2,163,001
+173,493
+9% +$2.43M 0.03% 808
2025
Q1 		$31.1M Sell
1,989,508
-524,069
-21% -$7.38M 0.04% 701
2024
Q4 		$35M Buy
2,513,577
+768,553
+44% +$8.42M 0.04% 729
2024
Q3 		$16.2M Buy
1,745,024
+737,640
+73% +$7.28M 0.02% 1118
2024
Q2 		$9.37M Buy
1,007,384
+790,518
+365% +$7.15M 0.01% 1377
2024
Q1 		$2.15M Buy
+216,866
New +$1.62M ﹤0.01% 2579
2023
Q2 		– Sell
-10,629
Closed -$117K – 4223
2023
Q1 		$117K Sell
10,629
-26,547
-71% -$384K ﹤0.01% 3968
2022
Q4 		$550K Sell
37,176
-37,200
-50% -$650K ﹤0.01% 3808
2022
Q3 		$1.42M Buy
+74,376
New +$1.69M ﹤0.01% 3308
2020
Q3 		– Sell
-9,546
Closed -$289K – 3815
2020
Q2 		$289K Buy
+9,546
New +$276K ﹤0.01% 3642

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return